Data as of Aug 27
| -0.09 / -2.69%|
The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +146.15% increase from the last price of 3.25.
The current consensus among 1 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.